Reposted by Matt SleincryoEM papers @cryoempapers.bsky.social · 09/09/2026Structure-based design of soluble prefusion-stabilized herpes simplex virus type 2 glycoprotein B antigens pubmed.ncbi.nlm.nih.gov/42709545/ #cryoEM 054
Reposted by Matt SleinNature Reviews Microbiology @natrevmicro.nature.com · 14/03/2026New online! Human herpesvirus evasion of humoral immunity and implications for vaccine developmentdlvr.itHuman herpesvirus evasion of humoral immunity and implications for vaccine developmentNature Reviews Microbiology, Published online: 13 March 2026; doi:10.1038/s41579-026-01295-xIn this Review, Otero et al. explore how human herpesviruses evade humoral immune responses and consider the resulting implications for developing effective vaccines and treatments for diseases caused by these common viral pathogens. 053
Matt Slein @mattslein.bsky.social · 09/03/2026The final portion of my PhD thesis is now live! Here we describe that both neutralziing and non neutralizing Abs targeting HSV gB require Fc effector functions to protect neonatal mice from infection. Thanks to all my coauthors, collaborators and thesis advisors! journals.asm.org/doi/10.1128/...journals.asm.orgAntibodies targeting HSV glycoprotein B require effector functions to protect neonatal mice | Journal of VirologyAntibodies represent promising drugs for the prevention and treatment of viral infections, especially when efficacious vaccines are unavailable. Determining the dominant mechanisms of Ab-mediated prot... 041
Reposted by Matt SleinbioRxiv Immunology @biorxiv-immuno.bsky.social · 25/02/2026Prefusion-specific glycoprotein B human antibodies protect against neonatal HSV-2 infection www.biorxiv.org/content/10.64898/20… 022
Reposted by Matt SleincryoEM papers @cryoempapers.bsky.social · 27/01/2026Structure-based design of soluble prefusion-stabilized herpes simplex virus type 2 glycoprotein B antigens www.biorxiv.org/content/10.64898/2026.01.26.701809v1 #cryoEM 075
Matt Slein @mattslein.bsky.social · 19/11/2025Excited to share a new publication from my PhD labs where we explore a method to improve antibody-mediated protection against herpes simplex virus infections: www.science.org/doi/10.1126/...science.orgEliminating interactions with the viral Fc receptor improves antibody-mediated protection against neonatal HSV infection in miceHSV-specific antibodies demonstrate improved activity in vitro and in vivo when the IgG Fc domain is rendered insensitive to the viral Fc receptor. 063
Reposted by Matt SleinJason McLellan @mclellanlab.bsky.social · 08/10/2025I'm honored to receive a MacArthur Fellowship. As always, I extend my sincerest thanks to all my wonderful mentors, colleagues, collaborators, admins, and trainees who make this work possible. #MacFellow 3222034
Matt Slein @mattslein.bsky.social · 09/10/2025Excited to have contributed to Volume 12 of Annual Review of Virology! www.annualreviews.org/content/jour...annualreviews.orgMaternal Antibodies to Neurovirulent Pathogens in Fetal TissuesInfection by neurovirulent pathogens in utero and during the neonatal period can lead to fetal and neonatal mortality as well as neurological morbidity with lifelong consequences. Fortunately, materna... 010
Matt Slein @mattslein.bsky.social · 30/07/2025Excited to share a portion of my PhD work describing the mechanisms of antibody-mediated protection against HSV infection. Here we show that a panel of 5 mAbs targeting gB all required Fc effector functions to be protective in a mouse model of neonatal HSV infection. www.biorxiv.org/content/10.1...biorxiv.orgAntibodies targeting HSV glycoprotein B require effector functions to protect neonatal miceGlycoprotein B (gB) serves as the viral fusion protein for herpes simplex virus (HSV), mediating fusion between viral and host membranes resulting in infection. As such, gB represents a potentially cr... 000
Reposted by Matt SleinDavid R. Martinez @davidmartinez.bsky.social · 12/06/2025A paper from our pancoronavirus vaccine P01 grant group is now out in Science Translational Medicine. Here we show that non-stabilized spike delivered as mRNA is sufficient to elicit broadly neutralizing antibodies in monkeys. @alexschaefer.bsky.social www.science.org/doi/10.1126/...science.orgNonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primatesNonstabilized SARS-CoV-2 spike mRNA vaccination elicited distinct antibodies to either Omicron variants of concern or preemergent sarbecoviruses. 042
Reposted by Matt SleinWaggoner Lab @labwaggoner.bsky.social · 30/05/2025Antibody-mediated restriction of M. tuberculosis is associated with reorganization of the tissue-level immune response to infection and depends on the collaboration of antibody Fab and Fc @cp-immunity.bsky.social Alter/Fortune www.cell.com/immunity/ful... 183
Matt Slein @mattslein.bsky.social · 21/04/2025A review I wrote for the upcoming issue of Annual Review of Virology is now live as a Review in Advance! tinyurl.com/ARV2025 Here we talk about the multifaceted role of maternal antibodies in protection against three important congenital viral infections. #virologytinyurl.comMaternal Antibodies to Neurovirulent Pathogens in Fetal Tissues | Annual ReviewsInfection by neurovirulent pathogens in utero and during the neonatal period can lead to fetal and neonatal mortality as well as neurological morbidity with lifelong consequences. Fortunately, materna... 010
Matt Slein @mattslein.bsky.social · 28/03/2025Successfully defended my thesis two weeks ago! Couldn’t have asked for better labs to do my PhD work in 020